Abstract
Although epidemiological studies have discerned the association between polycyclic aromatic hydrocarbons (PAHs) exposure and hypertension and/or cardiovascular disease in the general population, the possible mechanisms for this association are not well understood. We sought to examine the association between urinary metabolites of PAHs and cardiovascular diseases (CVDs) and blood pressure in adults, by conducting a meta-analysis of observational studies. We searched PubMed, Scopus, Embase, and Web of science, up to July 2021, for observational studies that investigated the association between urinary metabolites of PAHs and CVDs and blood pressure in adults. Nine prospective studies, including 27,280 participants, were included. Based on overall pooled results, there was a significant positive association between all types of urinary metabolites of PAH and blood pressure (OR: 1.32; 95%, CI: 1.19 to 1.48, p < 0.0001) (I2 = 62.4%, p < 0.0001). There was no significant association between any urinary metabolite of PAH and CHD (OR: 0.93; 95%, CI: 0.83 to 1.03, p = 0.174) (I2 = 0%, p = 0.653). Overall, there was a significant positive association between all urinary metabolites of PAH and CVD (OR: 1.23; 95%, CI: 1.16 to 1.30, p < 0.0001) (I2 = 59.7%, p < 0.0001). The results of the present meta-analysis suggest that different metabolites PAHs are associated with an increased risk of CVD and HTN. Further studies, including randomized clinical trials, are needed to confirm the veracity of our findings.
Similar content being viewed by others
Data and materials availability
Not applicable.
Abbreviations
- AhR:
-
Aryl hydrocarbon receptor
- BMI:
-
Body mass index
- CIs:
-
Confidence intervals
- CHD:
-
Coronary heart disease
- CVDs:
-
Cardiovascular diseases
- HR:
-
Hazard ratio
- HTN:
-
Hypertension
- 2-FLUO:
-
2-Hydroxyfluorene
- 9-FLUO:
-
9-Hydroxyfluorene
- IL-6:
-
Interleukin-6
- MDA:
-
Malondialdehyde
- MOOSE:
-
Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines
- NOS:
-
Newcastle–Ottawa scale
- 8iso PGF2:
-
8-Iso-prostaglandin-F2a
- 1-NAP:
-
1-Hydroxynaphthalene
- 2-NAP:
-
2-Hydroxynaphthalene
- OH-PAHs:
-
Monohydroxylated polycyclic aromatic hydrocarbons metabolites
- OR:
-
Odds ratio
- 8-ohdG:
-
8-Hydroxydeoxyguanosine
- PAHs:
-
Polycyclic aromatic hydrocarbons
- PRISMA:
-
Preferred Reporting Items for Systematic Reviews and Meta-Analyze
- PPAR-γ:
-
Peroxisome proliferator-activated receptor gamma
- PHEN:
-
Hydroxyphenanthrene
- 1-PYR:
-
1-Hydroxypyrene
- RR:
-
Relative risk
- TNF-α:
-
Tumor necrosis factor
- XMF:
-
Xenobiotic metabolic enzymes
References
Abbas Y, Lu W, Dai H, Fu X, Ye R, Wang H (2020) Remediation of polycyclic aromatic hydrocarbons (PAHs) contaminated soil with double dielectric barrier discharge plasma technology: Influencing parameters. Chem Eng J 394:124858
Adams K, Greenbaum DS, Shaikh R, van Erp AM, Russell AG (2015) Particulate matter components, sources, and health: Systematic approaches to testing effects. J Air Waste Manag Assoc 65(5):544–558
Akil L, Ahmad HA (2011) Relationships between obesity and cardiovascular diseases in four southern states and Colorado. J Health Care Poor Underserved 22(4 Suppl):61–72
Akpa OM, Made F, Ojo A, Ovbiagele B, Adu D, Motala AA, Mayosi BM, Adebamowo SN, Engel ME, Tayo B, Rotimi C, Salako B, Akinyemi R, Gebregziabher M, Sarfo F, Wahab K, Agongo G, Alberts M, Ali SA, Asiki G, Boua RP, Gómez-Olivé FX, Mashinya F, Micklesfield L, Mohamed SF, Nonterah EA, Norris SA, Sorgho H, Tollman S, Parekh RS, Chishala C, Ekoru K, Waddy SP, Peprah E, Mensah GA, Wiley K, Troyer J, Ramsay M, Owolabi MO (2020) Regional Patterns and Association Between Obesity and Hypertension in Africa. Hypertension 75(5):1167–1178
Alshaarawy O, Zhu M, Ducatman A, Conway B, Andrew ME (2013) Polycyclic aromatic hydrocarbon biomarkers and serum markers of inflammation. A positive association that is more evident in men. Environ Res 126:98–104
Alshaarawy O, Elbaz HA, Andrew ME (2016a) The association of urinary polycyclic aromatic hydrocarbon biomarkers and cardiovascular disease in the US population. Environ Int 89–90:174–178
Alshaarawy O, Elbaz HA, Andrew ME (2016b) The association of urinary polycyclic aromatic hydrocarbon biomarkers and cardiovascular disease in the US population. Environ Int 89:174–178
Araujo JA, Barajas B, Kleinman M, Wang X, Bennett BJ, Gong KW, Navab M, Harkema J, Sioutas C, Lusis AJ, Nel AE (2008) Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res 102(5):589–596
Archibong AE, Inyang F, Ramesh A, Greenwood M, Nayyar T, Kopsombut P, Hood DB, Nyanda AM (2002) Alteration of pregnancy related hormones and fetal survival in F-344 rats exposed by inhalation to benzo(a)pyrene. Reprod Toxicol 16(6):801–808
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC, Virani SS, Williams KA, Yeboah J, Ziaeian B (2019) 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 140(11):e563–e595
Ashraf MS, Vongpatanasin W (2006) Estrogen and hypertension. Curr Hypertens Rep 8(5):368–376
Bangia KS, Symanski E, Strom SS, Bondy M (2015) A cross-sectional analysis of polycyclic aromatic hydrocarbons and diesel particulate matter exposures and hypertension among individuals of Mexican origin. Environ Health 14:51
Bansal V, Kim K-H (2015) Review of PAH contamination in food products and their health hazards. Environ Int 84:26–38
Bhatnagar A (2006) Environmental cardiology: studying mechanistic links between pollution and heart disease. Circ Res 99(7):692–705
Bhatnagar A (2017) Environmental Determinants of Cardiovascular Disease. Circ Res 121(2):162–180
Bortey-Sam N, Ikenaka Y, Akoto O, Nakayama SMM, Asante KA, Baidoo E, Obirikorang C, Saengtienchai A, Isoda N, Nimako C, Mizukawa H, Ishizuka M (2017) Oxidative stress and respiratory symptoms due to human exposure to polycyclic aromatic hydrocarbons (PAHs) in Kumasi, Ghana. Environ Pollut 228:311–320
Boyland E, Kumura M, Sims P (1964) Metabolism of polycyclic compounds. 26. The hydroxylation of some aromatic hydrocarbons by the ascorbic acid model hydroxylating system and by rat-liver microsomes. Biochem J 92(3):631–638
Brook RD, Rajagopalan S (2009) Particulate matter, air pollution, and blood pressure. J Am Soc Hypertens 3(5):332–350
Brook RD, Rajagopalan S, Pope CA III, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA (2010) Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation 121(21):2331–2378
Brucker N, Moro AM, Charão MF, Durgante J, Freitas F, Baierle M, Nascimento S, Gauer B, Bulcão RP, Bubols GB, Ferrari PD, Thiesen FV, Gioda A, Duarte MMMF, de Castro I, Saldiva PH, Garcia SC (2013) Biomarkers of occupational exposure to air pollution, inflammation and oxidative damage in taxi drivers. Sci Total Environ 463–464:884–893
Brucker N, Charão MF, Moro AM, Ferrari P, Bubols G, Sauer E, Fracasso R, Durgante J, Thiesen FV, Duarte MM, Gioda A, Castro I, Saldiva PH, Garcia SC (2014) Atherosclerotic process in taxi drivers occupationally exposed to air pollution and co-morbidities. Environ Res 131:31–38
Cao L, Wang D, Zhu C, Wang B, Cen X, Chen A, Zhou H, Ye Z, Tan Q, Nie X (2020) Polycyclic aromatic hydrocarbon exposure and atherosclerotic cardiovascular disease risk in urban adults: The mediating role of oxidatively damaged DNA. Environ Pollut 265:114860
Cao L, Wang D, Zhu C, Wang B, Cen X, Chen A, Zhou H, Ye Z, Tan Q, Nie X, Feng X, Xie Y, Yuan J, Chen W (2020) Polycyclic aromatic hydrocarbon exposure and atherosclerotic cardiovascular disease risk in urban adults: The mediating role of oxidatively damaged DNA. Environ Pollut 265(Pt A):114860
Chan SH, Van Hee VC, Bergen S, Szpiro AA, DeRoo LA, London SJ, Marshall JD, Kaufman JD, Sandler DP (2015) Long-Term Air Pollution Exposure and Blood Pressure in the Sister Study. Environ Health Perspect 123(10):951–958
Costa G (2010) Shift Work and Health: Current Problems and Preventive Actions. Saf Health Work 1(2):112–123
Curfs DM, Knaapen AM, Pachen DM, Gijbels MJ, Lutgens E, Smook ML, Kockx MM, Daemen MJ, van Schooten FJ (2005) Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. Faseb j 19(10):1290–1292
Delfino RJ, Staimer N, Tjoa T, Arhami M, Polidori A, Gillen DL, Kleinman MT, Schauer JJ, Sioutas C (2010) Association of Biomarkers of Systemic Inflammation with Organic Components and Source Tracers in Quasi-Ultrafine Particles. Environ Health Perspect 118(6):756–762
Deng Q, Dai X, Guo H, Huang S, Kuang D, Feng J, Wang T, Zhang W, Huang K, Hu D, Deng H, Zhang X, Wu T (2014) Polycyclic Aromatic Hydrocarbons-Associated MicroRNAs and Their Interactions with the Environment: Influences on Oxidative DNA Damage and Lipid Peroxidation in Coke Oven Workers. Environ Sci Technol 48(7):4120–4128
Dubey RK, Oparil S, Imthurn B, Jackson EK (2002) Sex hormones and hypertension. Cardiovasc Res 53(3):688–708
Everett CJ, King DE, Player MS, Matheson EM, Post RE, Mainous AG (2010) Association of urinary polycyclic aromatic hydrocarbons and serum C-reactive protein. Environ Res 110(1):79–82
Ferguson KK, McElrath TF, Pace GG, Weller D, Zeng L, Pennathur S, Cantonwine DE, Meeker JD (2017) Urinary Polycyclic Aromatic Hydrocarbon Metabolite Associations with Biomarkers of Inflammation, Angiogenesis, and Oxidative Stress in Pregnant Women. Environ Sci Technol 51(8):4652–4660
Freitas F, Brucker N, Durgante J, Bubols G, Bulcao R, Moro A, Charao M, Baierle M, Nascimento S, Gauer B, Sauer E, Zimmer M, Thiesen F, Castro I, Saldiva P, Garcia SC (2014) Urinary 1-hydroxypyrene is associated with oxidative stress and inflammatory biomarkers in acute Myocardial Infarction. Int J Environ Res Public Health 11(9):9024–9037
Grimmer G, Jacob J, Dettbarn G, Naujack KW (1997) Determination of urinary metabolites of polycyclic aromatic hydrocarbons (PAH) for the risk assessment of PAH-exposed workers. Int Arch Occup Environ Health 69(4):231–239
Guengerich FP (2001) Forging the links between metabolism and carcinogenesis. Mutat Res 488(3):195–209
Hajat A, Diez-Roux AV, Adar SD, Auchincloss AH, Lovasi GS, O’Neill MS, Sheppard L, Kaufman JD (2013) Air Pollution and Individual and Neighborhood Socioeconomic Status: Evidence from the Multi-Ethnic Study of Atherosclerosis (MESA). Environ Health Perspect 121(11–12):1325–1333
Holme JA, Brinchmann BC, Refsnes M, Låg M, Øvrevik J (2019) Potential role of polycyclic aromatic hydrocarbons as mediators of cardiovascular effects from combustion particles. Environ Health 18(1):74
Hopman-Rock M, Westhoff MH (2000) The effects of a health educational and exercise program for older adults with osteoarthritis for the hip or knee. J Rheumatol 27(8):1947–1954
Hou J, Sun H, Guo Y, Zhou Y, Yin W, Xu T, Cheng J, Chen W, Yuan J (2018) Associations between urinary monohydroxy polycyclic aromatic hydrocarbons metabolites and Framingham Risk Score in Chinese adults with low lung function. Ecotoxicol Environ Saf 147:1002–1009
Hu C, Hou J, Zhou Y, Sun H, Yin W, Zhang Y, Wang X, Wang G, Chen W, Yuan J (2018) Association of polycyclic aromatic hydrocarbons exposure with atherosclerotic cardiovascular disease risk: a role of mean platelet volume or club cell secretory protein. Environ Pollut 233:45–53
Hunter DJ, Reddy KS (2013) Noncommunicable diseases. N Engl J Med 369(14):1336–1343
Irigaray P, Ogier V, Jacquenet S, Notet V, Sibille P, Méjean L, Bihain BE, Yen FT (2006) Benzo[a]pyrene impairs β-adrenergic stimulation of adipose tissue lipolysis and causes weight gain in mice. FEBS J 273(7):1362–1372
Jain RB (2020) Contributions of dietary, demographic, disease, lifestyle and other factors in explaining variabilities in concentrations of selected monohydroxylated polycyclic aromatic hydrocarbons in urine: Data for US children, adolescents, and adults. Environ Pollut 266(Pt 1):115178
Jeng HA, Pan CH, Diawara N, Chang-Chien GP, Lin WY, Huang CT, Ho CK, Wu MT (2011) Polycyclic aromatic hydrocarbon-induced oxidative stress and lipid peroxidation in relation to immunological alteration. Occup Environ Med 68(9):653–658
Jia C, James W, Kedia S (2014) Relationship of Racial Composition and Cancer Risks from Air Toxics Exposure in Memphis, Tennessee, U.S.A. Int J Environ Res Public Health 11(8):7713–7724
Khalil A, Villard P-H, Dao MA, Burcelin R, Champion S, Fouchier F, Savouret J-F, Barra Y, Seree E (2010) Polycyclic aromatic hydrocarbons potentiate high-fat diet effects on intestinal inflammation. Toxicol Lett 196(3):161–167
Kim JY, Lee SK, Kim CH, Jeon TW, Moon CK, Lee HS, Yoo SD, Lee ES, Jeong TC (2003) Effects of polycyclic aromatic hydrocarbons on liver and lung cytochrome P450s in mice. Arch Pharm Res 26(5):394–404
Kim JH, Yamaguchi K, Lee SH, Tithof PK, Sayler GS, Yoon JH, Baek SJ (2005) Evaluation of polycyclic aromatic hydrocarbons in the activation of early growth response-1 and peroxisome proliferator activated receptors. Toxicol Sci 85(1):585–593
Kim KH, Jahan SA, Kabir E, Brown RJ (2013) A review of airborne polycyclic aromatic hydrocarbons (PAHs) and their human health effects. Environ Int 60:71–80
Kuang D, Zhang W, Deng Q, Zhang X, Huang K, Guan L, Hu D, Wu T, Guo H (2013) Dose-Response Relationships of Polycyclic Aromatic Hydrocarbons Exposure and Oxidative Damage to DNA and Lipid in Coke Oven Workers. Environ Sci Technol 47(13):7446–7456
Larsson BK, Sahlberg GP, Eriksson AT, Busk LA (1983) Polycyclic aromatic hydrocarbons in grilled food. J Agric Food Chem 31(4):867–873
Lee T-W, Kim DH, Ryu JY (2020) Association between urinary polycyclic aromatic hydrocarbons and hypertension in the Korean population: data from the Second Korean National Environmental Health Survey (2012–2014). Sci Rep 10(1):1–8
Li J, Lu S, Liu G, Zhou Y, Lv Y, She J, Fan R (2015) Co-exposure to polycyclic aromatic hydrocarbons, benzene and toluene and their dose–effects on oxidative stress damage in kindergarten-aged children in Guangzhou, China. Sci Total Environ 524–525:74–80
Li W, Chen Z, Ruan W, Yi G, Wang D, Lu Z (2019) A meta-analysis of cohort studies including dose-response relationship between shift work and the risk of diabetes mellitus. Eur J Epidemiol 34(11):1013–1024
Lioy PJ, Greenberg A (1990) Factors associated with human exposures to polycyclic aromatic hydrocarbons. Toxicol Ind Health 6(2):209–223
Liu B, Jia C (2016) Effects of profession on urinary PAH metabolite levels in the US population. Int Arch Occup Environ Health 89(1):123–135
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J (2016) Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation 134(6):441–450
Motorykin O, Santiago-Delgado L, Rohlman D, Schrlau JE, Harper B, Harris S, Harding A, Kile ML, Massey Simonich SL (2015) Metabolism and excretion rates of parent and hydroxy-PAHs in urine collected after consumption of traditionally smoked salmon for Native American volunteers. Sci Total Environ 514:170–177
No author (2018a) Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1736–1788
No author (2018b) Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1923–1994
No author (n.d.a) c Inflammation with Cardiovascular Disease.pdf
No author (n.d.b) khosravipour2020.pdf
No author (n.d.c) Obesity and Hypertension.pdf
No author (n.d.d) PAH d serum inflammatory.pdf
No author (n.d.e) Polycyclic Aromatic Hydrocarbons on Ovulatory Status in Women.pdf
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499–511
Pelkonen O, Nebert DW (1982) Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev 34(2):189–222
Poursafa P, Moosazadeh M, Abedini E, Hajizadeh Y, Mansourian M, Pourzamani H, Amin MM (2017) A Systematic Review on the Effects of Polycyclic Aromatic Hydrocarbons on Cardiometabolic Impairment. Int J Prev Med 8:19
Poursafa P, Dadvand P, Amin MM, Hajizadeh Y, Ebrahimpour K, Mansourian M, Pourzamani H, Sunyer J, Kelishadi R (2018) Association of polycyclic aromatic hydrocarbons with cardiometabolic risk factors and obesity in children. Environ Int 118:203–210
Ramesh A, Walker SA, Hood DB, Guillén MD, Schneider K, Weyand EH (2004) Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol 23(5):301–333
Ramos KS, Moorthy B (2005) Bioactivation of polycyclic aromatic hydrocarbon carcinogens within the vascular wall: implications for human atherogenesis. Drug Metab Rev 37(4):595–610
Romero DL, Mounho BJ, Lauer FT, Born JL, Burchiel SW (1997) Depletion of glutathione by benzo(a)pyrene metabolites, ionomycin, thapsigargin, and phorbol myristate in human peripheral blood mononuclear cells. Toxicol Appl Pharmacol 144(1):62–69
Ruiz-Vera T, Pruneda-Álvarez LG, Ochoa-Martínez ÁC, Ramírez-GarcíaLuna JL, Pierdant-Pérez M, Gordillo-Moscoso AA, Pérez-Vázquez FJ, Pérez-Maldonado IN (2015) Assessment of vascular function in Mexican women exposed to polycyclic aromatic hydrocarbons from wood smoke. Environ Toxicol Pharmacol 40(2):423–429
Ruiz-Vera T, Ochoa-Martínez ÁC, Pruneda-Álvarez LG, Zarazúa S, Pérez-Maldonado IN (2019) Exposure to biomass smoke is associated with an increased expression of circulating miRNA-126 and miRNA-155 in Mexican women: a pilot study. 42(3): 335–342.
Samoli E, Atkinson RW, Analitis A, Fuller GW, Green DC, Mudway I, Anderson HR, Kelly FJ (2016) Associations of short-term exposure to traffic-related air pollution with cardiovascular and respiratory hospital admissions in London, UK. Occup Environ Med 73(5):300–307
Sancini A, Caciari T, Sinibaldi F, Sacco C, Boscolo P, Giubilati R, Scala B, Tomei G, Tomei F, Rosati MV (2014) Blood pressure changes and polycyclic aromatic hydrocarbons in outdoor workers. Clin Ter 165(4):e295-303
Sandoo A*, Veldhuijzen van Zanten JJCS, Metsios GS, Carroll D, Kitas GD. The Endothelium and Its Role in Regulating Vascular Tone
Schultz TW, Sinks GD (2002) Xenoestrogenic gene expression: structural features of active polycyclic aromatic hydrocarbons. Environ Toxicol Chem 21(4):783–786
Shi L, Lin L (2019) The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses. Medicine 98(23)
Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 56(13):2979–2984
Shiue I (2015a) Are urinary polyaromatic hydrocarbons associated with adult hypertension, heart attack, and cancer? USA NHANES, 2011–2012. Environ Sci Pollut Res Int 22(21):16962–16968
Shiue I (2015b) Are urinary polyaromatic hydrocarbons associated with adult hypertension, heart attack, and cancer? USA NHANES, 2011–2012. Environ Sci Pollut Res 22(21):16962–16968
Song Y, Wang J, Ge Y, Xu C (2020) An optimal parameters-based geographical detector model enhances geographic characteristics of explanatory variables for spatial heterogeneity analysis: Cases with different types of spatial data. Giscience & Remote Sens 57(5):593–610
Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012
Sun H, Shen O-X, Xu X-L, Song L, Wang X-R (2008) Carbaryl, 1-naphthol and 2-naphthol inhibit the beta-1 thyroid hormone receptor-mediated transcription in vitro. Toxicology 249(2):238–242
Sun H, Hou J, Zhou Y, Yang Y, Cheng J, Xu T, Xiao L, Chen W, Yuan J (2017) Dose-response relationship between urinary polycyclic aromatic hydrocarbons metabolites and urinary 8-hydroxy-2′-deoxyguanosine in a Chinese general population. Chemosphere 174:506–514
Urch B, Silverman F, Corey P, Brook JR, Lukic KZ, Rajagopalan S, Brook RD (2005) Acute blood pressure responses in healthy adults during controlled air pollution exposures. Environ Health Perspect 113(8):1052–1055
Vinggaard AM, Hnida C, Larsen JC (2000) Environmental polycyclic aromatic hydrocarbons affect androgen receptor activation in vitro. Toxicology 145(2):173–183
Wang Y, Yu Q, Chen Y, Cao F (2013) Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome. Curr Pharm Des 19(27):4799–4805
Wang Q, Xu X, Zeng Z, Hylkema MN, Cai Z, Huo X (2020) PAH exposure is associated with enhanced risk for pediatric dyslipidemia through serum SOD reduction. Environ Int 145:106132
Waterfall JF, Sims P (1972) Epoxy derivatives of aromatic polycyclic hydrocarbons. The preparation and metabolism of epoxides related to benzo(a)pyrene and to 7,8- and 9,10-dihydrobenzo(a)pyrene. Biochem J 128(2):265–277
Willerson JT, Ridker PM (2004) Inflammation as a Cardiovascular Risk Factor. Circulation 109(21_suppl_1):II-2-II–10
World Health O (2016) Hearts: technical package for cardiovascular disease management in primary health care. World Health Organization, Geneva
Xu X, Cook RL, Ilacqua VA, Kan H, Talbott EO, Kearney G (2010) Studying associations between urinary metabolites of polycyclic aromatic hydrocarbons (PAHs) and cardiovascular diseases in the United States. Sci Total Environ 408(21):4943–4948
Xu X, Hu H, Kearney GD, Kan H, Sheps DS (2013) Studying the effects of polycyclic aromatic hydrocarbons on peripheral arterial disease in the United States. Sci Total Environ 461–462:341–347
Yang L, Guo W, Zeng D, Ma L, Lai X, Fang Q, Guo H, Zhang X (2019) Heart rate variability mediates the association between polycyclic aromatic hydrocarbons exposure and atherosclerotic cardiovascular disease risk in coke oven workers. Chemosphere 228:166–173
Yin W, Hou J, Xu T, Cheng J, Li P, Wang L, Zhang Y, Wang X, Hu C, Huang C (2018) Obesity mediated the association of exposure to polycyclic aromatic hydrocarbon with risk of cardiovascular events. Sci Total Environ 616:841–854
Acknowledgements
We thank the School of Nutritional and Dietetics at Tehran University of Medical Sciences and participants in this investigation.
Author information
Authors and Affiliations
Contributions
The project was designed and implemented by AM and KhM. Data were analyzed and interpreted by AM, ED, SM1, FA, SM2, and OA, and CC prepared the manuscript. KhM supervised the overall project. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Responsible Editor: Lotfi Aleya
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Mirzababaei, A., Daneshzad, E., Moradi, S. et al. The association between urinary metabolites of polycyclic aromatic hydrocarbons (PAHs) and cardiovascular diseases and blood pressure: a systematic review and meta-analysis of observational studies. Environ Sci Pollut Res 29, 1712–1728 (2022). https://doi.org/10.1007/s11356-021-17091-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-021-17091-4